Psychiatric Care and Research Center

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Depression7 trials
• Bipolar disorder1 trial

Phase

• Phase 36 trials
• Phase 24 trials

Status

• Completed5 trials
• Active, not recruiting3 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Biohaven Pharmaceuticals, Inc.3 trials
• Xenon Pharmaceuticals Inc.3 trials
• Boehringer Ingelheim2 trials
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Supernus Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

  NCT07226661· Phase 2· Supernus Pharmaceuticals, Inc.· Source

  Contact: Gianpiera Ceresoli-Borroni, PhD

• Active, not recruiting

  A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

  NCT07172516· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  NCT07076407· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  An Open-Label Study of Azetukalner in Major Depressive Disorder

  NCT06922110· Phase 3· Xenon Pharmaceuticals Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression1 recruiting

Closed trials

• Completed

  A Study to Test Different Doses of BI 1569912 in People With Depression

  NCT06558344· Phase 2· Boehringer Ingelheim· Source

• Completed

  Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

  NCT05536414· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Terminated

  Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

  NCT04708834· Phase 3· Biohaven Pharmaceuticals, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

  NCT04693351· Phase 3· Biohaven Pharmaceuticals, Inc.· Source

• Completed

  Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

  NCT04641143· Phase 3· Biohaven Pharmaceuticals, Inc.· Source

• Completed

  A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

  NCT04521478· Phase 2· Boehringer Ingelheim· Source